Autolus Therapeutics plc Annual Net Income (Loss) Attributable to Parent in USD from 2016 to 2023

Taxonomy & unit
us-gaap: USD
Description
The portion of profit or loss for the period, net of income taxes, which is attributable to the parent.
Summary
Autolus Therapeutics plc quarterly/annual Net Income (Loss) Attributable to Parent history and growth rate from 2016 to 2023.
  • Autolus Therapeutics plc Net Income (Loss) Attributable to Parent for the quarter ending September 30, 2024 was -$82.1M, a 79.1% decline year-over-year.
  • Autolus Therapeutics plc Net Income (Loss) Attributable to Parent for the twelve months ending September 30, 2024 was -$270M, a 70.9% decline year-over-year.
  • Autolus Therapeutics plc annual Net Income (Loss) Attributable to Parent for 2023 was -$208M, a 40% decline from 2022.
  • Autolus Therapeutics plc annual Net Income (Loss) Attributable to Parent for 2022 was -$149M, a 4.75% decline from 2021.
  • Autolus Therapeutics plc annual Net Income (Loss) Attributable to Parent for 2021 was -$142M, a 0% decline from 2020.
Net Income (Loss) Attributable to Parent, Trailing 12 Months (USD)
Net Income (Loss) Attributable to Parent, Annual (USD)
Net Income (Loss) Attributable to Parent, YoY Annual Growth (%)
Period Value YoY Chg Change % Start Date End Date Report Filed
2023 -$208M -$59.5M -40% Jan 1, 2023 Dec 31, 2023 10-K 2024-03-21
2022 -$149M -$6.74M -4.75% Jan 1, 2022 Dec 31, 2022 10-K 2024-03-21
2021 -$142M -$2K 0% Jan 1, 2021 Dec 31, 2021 10-K 2024-03-21
2020 -$142M -$18.2M -14.7% Jan 1, 2020 Dec 31, 2020 20-F 2023-03-07
2019 -$124M -$79.1M -177% Jan 1, 2019 Dec 31, 2019 20-F 2022-03-10
2018 -$44.8M -$25M -127% Oct 1, 2017 Sep 30, 2018 20-F 2021-03-04
2017 -$19.7M -$7.18M -57.2% Oct 1, 2016 Sep 30, 2017 20-F 2020-03-03
2016 -$12.6M Oct 1, 2015 Sep 30, 2016 20-F 2019-02-25
* An asterisk sign (*) next to the value indicates that the value is likely invalid.